Health Care Facilities

Thomson Medical

Thomson Medical released FY2026 Q2 earnings on February 11 (SGT), actual revenue SGD 107.99 M, actual EPS SGD -0.0001

Thomson Medical released FY2026 Semi-Annual earnings on February 11 (SGT), actual revenue SGD 215.98 M, actual EPS SGD -0.0003

Thomson Medical released FY2026 Q1 earnings on February 11, 2026 (SGT) with actual revenue of SGD 107.99 M and EPS of SGD -0.0001

Thomson Medical released FY2025 9 Months earnings on August 29 (SGT), actual revenue SGD 328.76 M, actual EPS SGD -0.0011

Thomson Medical released FY2025 earnings on August 29 (SGT), actual revenue SGD 455.53 M (forecast SGD 414.05 M), actual EPS SGD -0.0017 (forecast SGD -0.0005)

Thomson Medical released FY2025 Q4 earnings on August 29, 2025 (SGT) with actual revenue of SGD 126.77M and EPS of SGD -0.0006

Thomson Medical released FY2025 Q3 earnings on August 29, 2025 (SGT) with actual revenue of SGD 126.77 M and EPS of SGD -0.0006

Singapore Jiali Medical and OncoCare Collaborate to Launch New Cancer Center

Thomson Medical released FY2025 Q2 earnings on February 12, 2025 (SGT), with actual revenue of 100.99 M SGD and EPS of -0.0002 SGD

Thomson Medical released FY2025 Semi-Annual Earnings on February 12, 2025 (SGT) with actual revenue of 201.98 M SGD and EPS of -0.0004 SGD

Thomson Medical released FY2025 Q1 earnings on February 12 (SGT), actual revenue 100.99 M SGD, actual EPS -0.0002 SGD

Thomson Medical released FY2024 Q3 earnings on August 26, 2024 (SGT) with actual revenue of SGD 105.75 M and EPS of SGD 0.0002

Thomson Medical released FY2024 9 Months Earnings on August 26 (SGT), actual revenue SGD 276.91 M, actual EPS SGD 0.0003

Thomson Medical released FY2024 Annual Earnings on August 26 (SGT), actual revenue SGD 382.65 M (forecast SGD 403.65 M), actual EPS SGD 0.0005 (forecast SGD 0.001)

Thomson Medical released FY2024 Q4 earnings on August 26 (SGT) with actual revenue of SGD 105.75 M and EPS of SGD 0.0002

SingtelMBeCW260730

Geely MB ePW261005

Abundance

Autagco

Asian Micro

HSI 28000MBePW260629

Teho

Alibaba MB eCW260703

Acesian Partners

NKY 55000MBePW260911

Thomson Medical Group (SGX:A50) reported half-year sales of S$213.08 million, up from S$199.06 million, with a narrower net loss of S$10.25 million. The company’s share price is S$0.06, reflecting a 3.45% return over three months and a 30.43% return over a year. The current price-to-sales (P/S) ratio is 3.4x, higher than industry averages, indicating potential overvaluation. However, a discounted cash flow analysis suggests a fair value of S$0.11 per share, indicating the stock may be undervalued. Investors are advised to consider these mixed signals when evaluating opportunities.

Simplywall

Thomson Medical Group (SGX:A50) Valuation Check After Narrower Losses And Higher Half Year Sales

Thomson Medical Group reported a loss of SGD 10.25 million in the first half of the 2026 fiscal year, a decrease from the loss of SGD 12.90 million in the previous year. At the same time, revenue increased by 7% year-on-year to SGD 21.308 million. The group released its earnings report after the market closed on Wednesday (February 11), indicating that the revenue growth was mainly due to increased income from its Singapore operations and contributions from its Malaysia oncology center. During this period, the number of consultations in Vietnam also increased, but some revenue was offset by foreign exchange fluctuations. "The revenue growth reflects that the group's core business continues to maintain growth momentum, and also demonstrates the progress made by the group in advancing its long-term transformation towards becoming a leading integrated healthcare platform in Southeast Asia." The group remains in a loss position, attributed to higher expenses related to digital transformation, marketing activities, depreciation, and amortization

Zaobao

In the first half of the year, Kangsheng Medical Group's losses narrowed to 10.25 million yuan | Lianhe Zaobao

Thomson Medical reported a narrowed net loss of S$10.2 million for H1 FY2026, down from S$12.9 million, driven by lower finance costs and steady operations. Revenue increased by 7% to S$213.1 million, attributed to growth in Singapore and Malaysia, despite foreign exchange impacts in Vietnam. The group plans to enhance its services and expand facilities, including a new fertility center and partnerships to boost medical tourism. Shares rose 1.6% to S$0.062 following the results announcement.

Businesstimes News

Thomson Medical narrows H1 net loss to S$10.2 million on lower finance costs, steady operations

Thomson Medical Group appointed Tong Guiwang as the new chairman, effective from February 1, succeeding Huang Simian. Tong Guiwang will assume the role of independent non-executive chairman, bringing extensive corporate management and investment experience, and is committed to promoting the group's development projects in the Johor Strait. Huang Simian has served as chairman since 2015, successfully leading the company's transformation and expansion. Thomson Medical Group's stock price fell 1.59% on Monday, closing at 0.062 SGD

Kangsheng Medical Group appoints new chairman, taking office on February 1 | Lianhe Zaobao

Thomson Medical Group plans to increase its investment in Vietnam by USD 381.4 million, despite an expected net loss in the fiscal year 2025. CEO Wang Junli stated that the group will focus on enhancing its capabilities rather than excessively expanding hospitals. In 2023, the group completed the acquisition of FV Hospital, which is the largest transaction in Vietnam's healthcare industry. FV Hospital is expanding its new wing, expected to be completed by the end of 2027, with a focus on enhancing oncology and surgical capabilities, as well as expanding medical insurance coverage. Wang Junli believes that Vietnam has the potential to become a regional medical center

Kangsheng Medical Group will increase investment in Vietnam to deepen regional layout | Lianhe Zaobao

Thomson Medical(A50.SG)

Thomson Medical Group (SGX:A50) Valuation Check After Narrower Losses And Higher Half Year Sales

In the first half of the year, Kangsheng Medical Group's losses narrowed to 10.25 million yuan | Lianhe Zaobao

Thomson Medical narrows H1 net loss to S$10.2 million on lower finance costs, steady operations

Kangsheng Medical Group appoints new chairman, taking office on February 1 | Lianhe Zaobao

Kangsheng Medical Group will increase investment in Vietnam to deepen regional layout | Lianhe Zaobao